Catalyst Wire Dossier Catalyst Wire Dossier

PEP005 (ingenol mebutate) gel 0.01%

ingenol mebutate · Peplin
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PEP005 (ingenol mebutate) gel 0.01%, covering 2015-09-09 to 2015-09-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers [Phase 1]

See pricing